Art

J-GLOBAL ID：202102284757414452   Reference number：21A0587611

Late-Onset Neutropenia in Long-Term Clozapine Use and Its Management Utilizing Prophylactic G-CSF

長期クロザピン使用における遅発性好中球減少症と予防的G-CSFを用いたその管理【JST・京大機械翻訳】

Author (4)： O' Neill Eimear (St. Stephen’s Psychiatric Hospital, Sarsfield Court, Glanmire, Cork, Ireland) ,  Carolan Deirdre (Mercy University Hospital, Glenville place, Cork, Ireland) ,  Kennedy Sarah (CUMH, Cork University Hospital, Wilton, Cork, Ireland) ,  Barry Sandra (Mercy University Hospital, Glenville place, Cork, Ireland)
Material： Case Reports in Psychiatry (Web)
Volume： 2021  Page： Null  Publication year： 2021 
JST Material Number： U7856A  ISSN： 2090-682X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： This case outlines recurrent n...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0587611&from=J-GLOBAL&jstjournalNo=U7856A") }}

Thesaurus term： lithium ,  sensitivity ,  side effect ,  prevention ,  *neutrophils ,  *neutropenia ,  antipsychotic agent ,  *G-CSF ,  nitrogen heterocyclic compound ,  aromatic ketone ,  aromatic fluorine compound ,  aromatic chlorine compound ,  dopamine antagonist ,  hydroxy compound ,  polynuclear aromatic compound
Semi thesaurus term： フィルグラスチム ,  血液学 ,  治療抵抗性統合失調症 ,  後期発症 , 【Automatic Indexing@JST】

JST classification (2)： Clinical application of drugs acting on blood and body fluid  (GW14020X) ,  Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P)

Substance index (2)： Haloperidol ,  Clozapine

Reference (15)：

• D. Siskind, V. Siskind, S. Kisely, "Clozapine response rates among people with treatment resistant schizophrenia: data from a systematic review and meta-analysis," Canadian Journal of Psychiatry, vol. 62, no. 11, pp. 772-777, 2017.
• A. L. Gillespie, R. Samanaite, J. Mill, A. Egerton, J. H. MacCabe, "Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review," BMC Psychiatry, vol. 17, no. 1, 2017.
• J. L. Kennedy, C. A. Altar, D. L. Taylor, I. Degtiar, J. C. Hornberger, "The social and economic burden of treatment-resistant schizophrenia," International Clinical Psychopharmacology, vol. 29, no. 2, pp. 63-76, 2014.
• A. S. Silveira, D. M. L. V. Rocha, C. R. F. Attux, C. S. Daltio, L. A. Silva, H. Elkis, J. M. Kane, R. A. Bressan, "Patterns of clozapine and other antipsychotics prescriptions in patients with treatment-resistant schizophrenia in community mental health centers in São Paulo, Brazil," Archives of Clinical Psychiatry (São Paulo), vol. 42, no. 6, pp. 165-170, 2015.
• British Medical Association, Royal Pharmaceutical Society of Great Britain, British National Formulary 73, BMJ Group, London, 2017.

Terms in the title (5)： 長期 ,  クロザピン ,  遅発性 ,  好中球減少症 ,  予防